|
||||||||
![]() |
||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The vector sequence has been compiled using the information from sequence databases, published literature, and other sources, together with partial sequences obtained by Evrogen. This vector has not been completely sequenced. |
|||||||||||||||||||||||||||||||||||||||||||||||||
![]() Download
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
| Bgl II | Sac I | Hind III | EcoR I | Sal I | Kpn I | Apa I | BamH I | Age I | TurboYFP | ||||||||||||||||||
| Afe I | Xho I | Pst I | Sac II* | ||||||||||||||||||||||||
| ACT | A.GC | G.CT | A.CCG.GAC.TC | A.GAT. | CT | C. | GAG. | CTC. | AAG.CTT. | C | GA.ATT. | C | TG.CA | G. | TCG.AC | G.GTA. | CC | G.C | GG. | G | CC.C | G | G.G | AT.CC | A.CCG.GT | C.GCC.ACC. | ATG.AGC.AGC |
* – not unique site.
pTurboYFP-PRL is a promoterless vector encoding yellow fluorescent protein TurboYFP, which can be used as in vivo reporter of promoter activity (see reporter description). TurboYFP codon usage is optimized for high expression in mammalian cells (humanized) [Haas et al., 1996]. To increase mRNA translation efficiency, Kozak consensus translation initiation site is generated upstream of the TurboYFP coding sequence [Kozak, 1987].
Multiple cloning site (MCS) is located upstream of the Kozak consensus translation initiation site and can be used to clone a promoter or a promoter/enchancer combination of interest. Without the addition of a functional promoter, this vector will not express TurboYFP.
The vector backbone contains SV40 origin for replication in mammalian cells expressing SV40 T-antigen, pUC origin of replication for propagation in
SV40 early promoter (PSV40) provides neomycin resistance gene (Neor) expression to select stably transfected eukaryotic cells using G418. Bacterial promoter (P) provides kanamycin resistance gene expression (Kanr) in
Note: The plasmid DNA was isolated from dam+-methylated
Propagation in
Suitable host strains for propagation in
Location of features
MCS: 12-89
TurboYFP
Kozak consensus translation initiation site: 90-100
Start codon (ATG): 97-99
Stop codon: 826-828
SV40 early mRNA polyadenylation signal
Polyadenylation signals: 982-987 & 1011-1016
mRNA 3' ends: 1020 & 1032
f1 single-strand DNA origin: 1079-1534
Bacterial promoter for expression of Kanr gene
-35 region: 1596-1601
-10 region: 1619-1624
Transcription start point: 1631
SV40 origin of replication: 1875-2010
SV40 early promoter
Enhancer (72-bp tandem repeats): 1708-1779 & 1780-1851
21-bp repeats: 1855-1875, 1876-1896 & 1898-1918
Early promoter element: 1931-1937
Major transcription start points: 1927, 1965, 1971 & 1976
Kanamycin/neomycin resistance gene
Neomycin phosphotransferase coding sequences:
Start codon (ATG): 2059-2061
Stop codon: 2851-2853
G->A mutation to remove Pst I site: 2241
C->A (Arg to Ser) mutation to remove BssH II site: 2587
Herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signal
Polyadenylation signals: 3089-3094 & 3102-3107
pUC plasmid replication origin: 3438-4081
Evrogen Fluorescent Protein Products (the Products) are intended for research use only. The Products are covered by Evrogen Patents and/or Patent applications pending. By use of these Products, you accept the terms and conditions of the applicable Limited Use Label License.
|
Copyright 2002-2011 Evrogen. All rights reserved. Evrogen JSC, 16/10 Miklukho-Maklaya str., Moscow, Russia, Tel +7(495)988-4084, Fax +7(495)988-4085, e-mail:evrogen@evrogen.com |